Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments

v3.21.2
Derivative Financial Instruments
6 Months Ended
Jun. 30, 2020
Investments, All Other Investments [Abstract]  
Derivative Financial Instruments

7. DERIVATIVE FINANCIAL INSTRUMENTS

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. The hierarchy is broken down into three levels based on the observability of inputs as follows:

 

  Level 1 — Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment;
  Level 2 — Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and
  Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Our derivative liabilities are measured at fair value on a recurring basis and estimated as follows:

 

June 30, 2020   Level 1     Level 2     Level 3     Total  
Derivative liabilities                 273,499       273,499  
ARO liabilities                 2,679,745       2,679,745  
                                 
December 31, 2019                                
Derivative liabilities                 24,509       24,509  
ARO liabilities                 1,723,364       1,723,364  

 

On May 18, 2018, as an inducement to enter into an Amended and Restated Loan Agreement, the Company issued, among other instruments, warrants to acquire 320,000 shares of common stock with an exercise price of $0.10 per share in Canadian dollars (see Note 5). The warrants are valued using the Black Scholes Option Pricing Model and the derivative is fair valued at the end of each reporting period. The Company valued the derivative liability at initial recognition as $30,013.

 

On January 2, 2020, as an inducement to enter into a Loan Agreement, the Company issued warrants to purchase 5,000,000 shares of common stock with an exercise price of $0.10 per share in Canadian dollars (see Note 5) and expire in 36 months. The warrants are valued using the Black Scholes Option Pricing Model and the derivative is fair valued at the end of each reporting period. The Company valued the derivative liability at initial recognition as $144,259.

 

A summary of the activity of the Company’s derivative liabilities is shown below:

 

Balance, January 1, 2019   $ 37,013  
Additions      
Fair value adjustments     (12,504 )
As at December 31, 2019     24,509  
Additions     144,259  
Fair value adjustment     104,731  
As at June 30, 2020   $ 273,499  

 

Derivative liability classified warrants were valued using the Black Scholes Option Pricing Model with the range of assumptions outlined below. Expected life was determined based on historical exercise data of the Company.

 

    June 30, 2020     December 31, 2019  
Risk-free interest rate     2.27 %     1.58% - 2.27 %
Expected life     2.1 years       1.4 – 2.1 years  
Expected dividend rate     0 %     0 %
Expected volatility     208 %     208% - 240 %